173 results on '"Dunavin, Neil"'
Search Results
2. A Phase I Study to Evaluate Two Doses of Wharton’s Jelly-Derived Mesenchymal Stromal Cells for the Treatment of De Novo High-Risk or Steroid-Refractory Acute Graft Versus Host Disease
3. Utility of routine surveillance imaging for diffuse large B-cell lymphoma post autologous transplant: A single center experience
4. Functional cooperativity of p97 and histone deacetylase 6 in mediating DNA repair in mantle cell lymphoma cells
5. P536: A FIRST-IN-HUMAN PHASE 1 STUDY OF IO-202 (ANTI-LILRB4 MAB) IN ACUTE MYELOID LEUKEMIA (AML) WITH MONOCYTIC DIFFERENTIATION AND CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) PATIENTS
6. HLA-DPB1 Mismatch Permissiveness and Activating KIR Haplotypes Have Different Impact on Allogeneic Hematopoietic Cell Transplant Survival Outcomes in Acute Leukemias and Myelodysplastic Syndrome
7. Improved Gvhd and Relapse Free Survival Outcomes in Older Acute Leukemia Patients Receiving Young Haploidentical Donor Vs Older Matched Sibling Donor Reduced Intensity Conditioning Hematopoietic Cell Transplants
8. Contributors
9. Upregulation of chemokine CXCL10 enhances chronic pulmonary inflammation in tree shrew collagen-induced arthritis
10. CD34+ selection and the severity of oropharyngeal mucositis in total body irradiation-based allogeneic stem cell transplantation
11. A Case of EBV-Negative Aggressive NK-cell Leukemia: Use of Next-Generation Sequencing in Demystifying a Diagnostic Dilemma and Guiding Clinical Care
12. A First-in-Human Phase 1 Study of the Menin-KMT2A (MLL1) Inhibitor JNJ-75276617 in Adult Patients with Relapsed/Refractory Acute Leukemia Harboring KMT2A or NPM1 Alterations
13. WJMSC‐derived small extracellular vesicle enhance T cell suppression through PD‐L1
14. 304 - HLA-DPB1 Mismatch Permissiveness and Activating KIR Haplotypes Have Different Impact on Allogeneic Hematopoietic Cell Transplant Survival Outcomes in Acute Leukemias and Myelodysplastic Syndrome
15. Adherent cell depletion promotes the expansion of renal cell carcinoma infiltrating T cells with optimal characteristics for adoptive transfer
16. Conditioning Regimen Intensity May Affect Outcome in MDS Patients Undergoing Allogeneic Stem Cell Transplantation, Depending on MDS Subgroup
17. LAG3 Inhibition Decreases AML-Induced Immunosuppression and Improves T Cell-Mediated Killing
18. The Activation Marker CD137 (4-1BB) Identifies a Highly Active Subset of Donor Lymphocytes Against Acute Myeloid Leukemia
19. Cellular immune profiling after sequential clofarabine and lenalidomide for high risk myelodysplastic syndromes and acute myeloid leukemia
20. Biomarker profiling of steroid-resistant chronic GvHD patients undergoing extracorporeal photopheresis demonstrates high ST2 levels at treatment onset and decline during therapy
21. Daratumumab, Pomalidomide, and Dexamethasone (DPd) As Salvage Treatment for Relapsed/Refractory Myeloma Eligible for High-Dose Chemotherapy/Autologous Stem Cell Transplantation
22. Health Care Reimbursement and Service Utilization Among Medicare Beneficiaries with Multiple Myeloma Receiving Autologous Hematopoietic Cell Transplantation in Inpatient and Outpatient Settings
23. LAG3 Promotes Acute Myeloid Leukemia-Induced Immune Suppression
24. Daratumumab, Pomalidomide, and Dexamethasone (DPd) for the Treatment of Relapsed/Refractory Multiple Myeloma: A Single Institution Experience
25. CRISPR/Cas9-Mediated Disruption of PD-L1 Reduces the T Cell Suppressive Effect of Wharton's Jelly Mesenchymal Stromal Cells and Their Extracellular Vesicles
26. Outcomes of VDPACE with Immunomodulator Agent as a Salvage Therapy for Relapsed/Refractory Multiple Myeloma
27. Mesenchymal stromal cell infusions for acute graft-versus-host disease: Rationale, data, and unanswered questions
28. Using Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) Tool to Explore Quality of Life in Patients Undergoing Autologous Stem Cell Transplantation in the Outpatient Setting
29. Vancomycin-Resistant Enterococcus Faecium (VRE) Fecal Colonization and Early Outcomes of Allogeneic Hematopoietic Stem Cell Transplant (Allo-HCT)
30. Impact of Cell of Origin on Outcomes in DLBCL Patients Undergoing Autologous Stem Cell Transplant (Auto-HCT)
31. Utility of Routine Surveillance Imaging for Hodgkin Disease following Autologous Transplant: Experiences from a Single Institution
32. Mesenchymal Stromal Cells: What Is the Mechanism in Acute Graft-Versus-Host Disease?
33. Differences in outcomes between patients whose relapse was diagnosed radiologically versus clinically after autologous transplantation for relapsed/refractory diffuse large B-cell lymphoma.
34. Monitoring Therapeutic Efficacy of Mesenchymal Stromal Cell Infusions By Serial Measurements of Acute Graft-Versus-Host Disease Biomarkers
35. Clofarabine Followed By Lenalidomide for Treatment of High Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia- Preliminary Clinical Outcomes and Potential Immune-Modulating Effects
36. Epigenetic landscape of the TERT promoter: a potential biomarker for high risk AML/MDS
37. Improved Reproducibility of Gvhd Biomarker Assay- Application of Multiplex Microfluidic Channel System
38. ST2 is Associated with GVHD in Ex Vivo Graft Manipulation Strategies for Allogeneic Peripheral Blood Stem Cell Transplantation
39. 446 - Vancomycin-Resistant Enterococcus Faecium (VRE) Fecal Colonization and Early Outcomes of Allogeneic Hematopoietic Stem Cell Transplant (Allo-HCT)
40. 299 - Using Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) Tool to Explore Quality of Life in Patients Undergoing Autologous Stem Cell Transplantation in the Outpatient Setting
41. 159 - Impact of Cell of Origin on Outcomes in DLBCL Patients Undergoing Autologous Stem Cell Transplant (Auto-HCT)
42. A First-in-Human Phase 1 Study of the Menin-KMT2A (MLL1) Inhibitor JNJ-75276617 in Adult Patients with Relapsed/Refractory Acute Leukemia Harboring KMT2Aor NPM1Alterations
43. Activity of the Telomerase Inhibitor GRN163L (Imetelstat) on Acute Myeloblastic Leukemia Blasts Is Enhanced By DNA Methyltransferase Inhibitors Irrespective of TERT Promoter Methylation Status
44. CD34+ selection and the severity of oropharyngeal mucositis in total body irradiation-based allogeneic stem cell transplantation
45. Clinical and laboratory predictors impacting allogeneic peripheral blood stem cell mobilization
46. Minor ABO Incompatibility Does Not Impact Nonrelapse Mortality in T Cell–Depleted Human Leukocyte Antigen–Matched Sibling Transplantation
47. Cardiac CT Imaging Is a Feasible Screening Strategy for Coronary Artery Disease (CAD) in Long Term Allogeneic Stem Cell Transplant (Allo-SCT) Survivors
48. Minor ABO Incompatibility Does Not Impact Non-Relapse Mortality in T-Cell Depleted HLA-Matched Sibling Transplantation
49. Bone Mineral Density (BMD) Improves in Survivors in Their Second Decade Post-Allogeneic Stem Cell Transplantation and Is Influenced By Body Mass Index (BMI) and Age
50. Blood Stream Infection Is Frequent during Conditioning but Does Not Impact Allogeneic Transplant Outcomes in the Modern Era
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.